Pulmonary manifestations of Sjögren's syndrome

Presse Medicale

Volumn 40, Issue 1 PART2, 2011, Pages

  Hatron, Pierre Yves ^a   Tillie Leblond, Isabelle ^a   Launay, David ^a   Hachulla, Eric ^a   Fauchais, Anne Laure ^b   Wallaert, Benoît ^a  

^a UNIV LILLE   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ERYTHROMYCIN; IMMUNOSUPPRESSIVE AGENT; PROSTACYCLIN; RITUXIMAB; SILDENAFIL;

AMYLOIDOSIS; B CELL LYMPHOMA; BRONCHIECTASIS; BRONCHIOLITIS; CELL INFILTRATION; COUGHING; EXPIRATORY RESERVE VOLUME; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LOW DRUG DOSE; LUNG CYST; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MARGINAL ZONE LYMPHOMA; ORGANIZING PNEUMONIA; PLEURA DISEASE; PREVALENCE; PULMONARY HYPERTENSION; PULMONARY VASCULITIS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INJURY; SHORT SURVEY; SJOEGREN SYNDROME; SURVIVAL RATE; TOTAL LUNG CAPACITY; TRACHEOBRONCHITIS;

EID: 84863836481     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.11.002     Document Type: Short Survey

References (146)

1. Gondran G., Fauchais A., Lambert M., Ly K., Launay D., Queyrel V., et al. Primary Sjögren's syndrome in men. Scand J Rheumatol 2008, 37(4):300-305.
2. García-Carrasco M., Ramos-Casals M., Rosas J., Pallarés L., Calvo-Alen J., Cervera R., et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002, 81(4):270-280.
3. Kassan S.S., Thomas T.L., Moutsopoulos H.M., Hoover R., Kimberly R.P., Budman D.R., et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978, 89(6):888-892.
4. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L.T. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006, 65(6):796-803.
5. Alamanos Y., Tsifetaki N., Voulgari P.V., Venetsanopoulou A.I., Siozos C., Drosos A.A. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006, 45(2):187-191.
6. Bowman S.J., Ibrahim G.H., Holmes G., Hamburger J., Ainsworth J.R. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004, 33(1):39-43.
7. Strimlan C.V., Rosenow E.C.3rd, Divertie M.B., Harrison E.G. Pulmonary manifestations of Sjögren's syndrome. Chest 1976, 70(03):354-361.
8. Davidson B.K., Kelly C.A., Griffiths I.D. Ten year follow up of pulmonary function in patients with primary Sjögren's syndrome. Ann Rheum Dis 2000, 59(9):709-712.
9. Yazisiz V., Arslan G., Ozbudak I.H., Turker S., Erbasan F., Avci A.B., et al. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?. Rheumatol Int 2010, 30(10):1317-1324.
10. Fauchais A.L., Martel C., Gondran G., Lambert M., Launay D., Jauberteau M.O., et al. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 2010, 9(9):595-599.
11. Kelly C., Gardiner P., Pal B., Griffiths I. Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study. Thorax 1991, 46(3):180-183.
12. Constantopoulos S.H., Papadimitriou C.S., Moutsopoulos H.M. Respiratory manifestations in primary Sjögren's syndrome. A clinical, functional, and histologic study. Chest 1985, 88(2):226-229.
13. Papiris S.A., Maniati M., Constantopoulos S.H., Roussos C., Moutsopoulos H.M., Skopouli F.N. Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999, 58(1):61-64.
14. Franquet T., Giménez A., Monill J.M., Díaz C., Geli C. Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. Am J Roentgenol 1997, 169(3):655-658.
15. Matsuyama N., Ashizawa K., Okimoto T., Kadota J., Amano H., Hayashi K. Pulmonary lesions associated with Sjögren's syndrome: radiographic and CT findings. Br J Radiol 2003, 76(912):880-884.
16. Hatron P.Y., Wallaert B., Gosset D., Tonnel A.B., Gosselin B., Voisin C., et al. Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum 1987, 30(11):1226-1231.
17. Brito-Zerón P., Ramos-Casals M., Bove A., Sentis J., Font J. Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors. Rheumatology (Oxford) 2007, 46(8):1359-1362.
18. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002, 46(3):741-747.
19. Parambil J.G., Myers J.L., Lindell R.M., Matteson E.L., Ryu J.H. Interstitial lung disease in primary Sjögren syndrome. Chest 2006, 130(5):1489-1495.
20. Ziza J.M., Kaplan G., Salomon C., Kahn M.F. Severe pulmonary fibrosis disclosing primary Gougerot-Sjögren syndrome. Ann Med Interne (Paris) 1986, 137(1):46-50.
21. Papadimitraki E.D., Kyrmizakis D.E., Kritikos I., Boumpas D.T. Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol 2004, 22:485-494.
22. Papiris S.A., Saetta M., Turato G., La Corte R., Trevisani L., Mapp C.E., et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. Am J Respir Crit Care Med 1997, 156:637-641.
23. Amin K., Lúdvíksdóttir D., Janson C., Nettelbladt O., Gudbjörnsson B., Valtysdóttir S., et al. Bronchial hyper-responsiveness. Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome. Respir Med 2001, 95:904-910.
24. Ito I., Nagai S., Kitaichi M., Nicholson A.G., Johkoh T., Noma S., et al. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005, 171(6):632-638.
25. Fortoul T.I., Cano-Valle F., Oliva E., Barrios R. Follicular bronchiolitis in association with connective tissue diseases. Lung 1985, 163:305-314.
26. Gardiner P., Ward C., Allison A., Ashcroft T., Simpson W., Walters H., et al. Pleuropulmonary abnormalities in primary Sjögren's syndrome. J Rheumatol 1993, 20:831-837.
27. Newball H.H., Brahim S.A. Chronic obstructive airway disease in patients with Sjögren's syndrome. Am Rev Respir Dis 1977, 115:295-304.
28. Wells A.U., du Bois R.M. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993, 14:655-666.
29. Gudbjornsson B., Hedenstrom H., Stalenheim G., Hallgren R. Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren's syndrome. Ann Rheum Dis 1991, 50:36-40.
30. Mathieu A., Cauli A., Pala R., Satta L., Nurchis P., Loi G.L., et al. Tracheo-bronchial mucociliary clearance in patients with primary and secondary Sjögren's syndrome. Scand J Rheumatol 1995, 24:300-304.
31. Andoh Y., Shimura S., Sawai T., Sasaki H., Takishima T., Shirato K. Morphometric analysis of airways in Sjögren's syndrome. Am Rev Respir Dis 1993, 148:1358-1362.
32. Pirildar T., Gumuser G., Ruksen E., Sakar A., Dinc G., Sayit E. Assessment of alveolar epithelial permeability with Tc-99m DTPA aerosol scintigraphy in patients with Sjögren syndrome. Rheumatol Int. 2010, 30:599-604.
33. Mialon P., Barthelemy L., Sebert P., Le Henaff C., Sarni D., Pennec Y.L., et al. A longitudinal study of lung impairment in patients with primary Sjögren'syndrome. Clin Exp Rheumatol 1997, 15:349-354.
34. Uffmann M., Kiener H.P., Bankier A.A., Baldt M.M., Zontsich T., Herold C.J. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 2001, 16:282-289.
35. Koyama M., Johkoh T., Honda O., Mihara N., Kozuka T., Tomiyama N., et al. Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 2001, 16:290-296.
36. Taouli B., Brauner M.W., Mourey I., Lemouchi D., Grenier P.A. Thin-section chest CT findings of primary Sjögren's syndrome: correlation with pulmonary function. Eur Radiol 2002, 12:1504-1511.
37. Lohrmann C., Uhl M., Warnatz K., Ghanem N., Kotter E., Schaefer O., et al. High-resolution CT imaging of the lung for patients with primary Sjögren's syndrome. Eur J Radiol 2004, 52:137-143.
38. Lahdensuo, Korpela AM. Pulmonary findings in patients with primary Sjögren's syndrome. Chest 1995:108:316-9.
39. Garcia G., Perez T., Mahut B. Lung function testing and assessment of distal airways in asthma. Rev Mal Respir 2009, 26:395-406.
40. Lúdvíksdóttir D., Janson C., Högman M., Gudbjörnsson B., Björnsson E., Valtýsdóttir S., et al. Increased nitric oxide in expired air in patients with Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Eur Respir J 1999, 13:739-743.
41. Segal I., Fink G., Machtey I., Gura V., Spitzer S.A. Pulmonary function abnormalities in Sjögren's syndrome and the sicca complex. Thorax 1981, 36:286-289.
42. Pertovaara M., Korpela M., Saarelainen S., Laitinen J., Järvenpää R., Laippala P., et al. Long-term follow-up study of pulmonary findings in patients with primary Sjögren's syndrome. Scand J Rheumatol 2004, 33:343-348.
43. Chen H.A., Lai S.L., Kwang W.K., Liu J.C., Chen C.H., Huang D.F. Middle lobe syndrome as the pulmonary manifestation of primary Sjögren's syndrome. Med J Aust 2006, 184:294-295.
44. White E.S., Tazelaar H.D., Lynch J.P.3rd Bronchiolar complications of connective tissue diseases. Semin Respir Crit Care Med 2003, 24:543-566.
45. Crestani B., Schneider S., Adle-Biassette H., Debray M.P., Bonay M., Aubier M. Respiratory manifestations during the course of Sjögren's syndrome. Rev Mal Respir 2007, 24:535-551.
46. Crestani B., Schneider S. Respiratory symptoms in the Gougerot-Sjögren syndrome. Rev Mal Respir 2006, 23:751-753.
47. La Corte R., Bajocchi G., Potena A., Govoni M., Trotta F. Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjögren's syndrome. Ann Rheum Dis 1995, 54:636-639.
48. La Corte R., Potena A., Bajocchi G., Fabbri L., Trotta F. Increased bronchial responsiveness in primary Sjögren's syndrome. A sign of tracheobronchial involvement. Clin Exp Rheumatol 1991, 9:125-130.
49. Potena A., La Corte R., Fabbri L.M., Papi A., Trotta F., Ciaccia A. Increased bronchial responsiveness in primary and secondary Sjögren's syndrome. Eur Respir J 1990, 3:548-553.
50. Stalenheim G., Gudbjornsson B. Anti-inflammatory drugs do not alleviate bronchial hyperreactivity in Sjögren's syndrome. Allergy 1997, 52:423-427.
51. Ludviksdottir D., Janson C., Bjornsson E., Stalenheim G., Boman G., Hedenstrom H., et al. Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy 2000, 55:259-265.
52. Fairfax A.J., Haslam P.L., Pavia D., Sheahan N.F., Bateman J.R., Agnew J.E., et al. Pulmonary disorders associated with Sjögren's syndrome. Q J Med 1981, 50:279-295.
53. Strimlan C.V. Pulmonary involvement in Sjögren's syndrome. Respiration 1986, 49:311.
54. Franquet T., Diaz C., Domingo P., Gimenez A., Geli C. Air trapping in primary Sjögren syndrome: correlation of expiratory CT with pulmonary function tests. J Comput Assist Tomogr 1999, 23:169-173.
55. Devaraj A., Wells A.U., Hansell D.M. Computed tomographic imaging in connective tissue diseases. Semin Respir Crit Care Med 2007, 28:389-397.
56. Desai S.R., Veeraraghavan S., Hansell D.M., Nikolakopolou A., Goh N.S., Nicholson A.G., et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004, 232:560-567.
57. Honda O., Johkoh T., Ichikado K., Tomiyama N., Maeda M., Mihara N., et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol 1999, 173:71-74.
58. Oxholm P., Bundgaard A., Birk Madsen E., Manthorpe R., Vejlo Rasmussen F. Pulmonary function in patients with primary Sjögren's syndrome. Rheumatol Int 1982, 2:179-181.
59. Bariffi F., Pesci A., Bertorelli G., Manganelli P., Ambanelli U. Pulmonary involvement in Sjögren's syndrome. Respiration 1984, 46:82-87.
60. Papathanasiou M.P., Constantopoulos S.H., Tsampoulas C., Drosos A.A., Moutsopoulos H.M. Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome. A controlled study. Chest 1986, 90:370-374.
61. Salaffi F., Manganelli P., Carotti M., Baldelli S., Blasetti P., Subiaco S., et al. A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol 1998, 37:263-269.
62. Franquet T., Muller N.L. Disorders of the small airways: high-resolution computed tomographic features. Semin Respir Crit Care Med 2003, 24:437-444.
63. Wallaert B., Hatron P.Y., Grosbois J.M., Tonnel A.B., Devulder B., Voisin C. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis 1986, 133:574-580.
64. Wallaert B., Prin L., Hatron P.Y., Ramon P., Tonnel A.B., Voisin C. Lymphocyte subpopulations in bronchoalveolar lavage in Sjögren's syndrome. Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia. Chest 1987, 92:1025-1031.
65. Wallaert B., Bart F., Aerts C., Ouaissi A., Hatron P.Y., Tonnel A.B., et al. Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases. Thorax 1988, 43:24-30.
66. Wallaert B., Dugas M., Dansin E., Perez T., Marquette C.H., Ramon P., et al. Subclinical alveolitis in immunological systemic disorders. Transition between health and disease?. Eur Respir J 1990, 3:1206-1216.
67. Dalavanga Y.A., Constantopoulos S.H., Galanopoulou V., Zerva L., Moutsopoulos H.M. Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome. Chest 1991, 99:1394-1397.
68. Deheinzelin D., Capelozzi V.L., Kairalla R.A., Barbas Filho J.V., Saldiva P.H., de Carvalho C.R. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996, 154:794-799.
69. Yamadori I., Fujita J., Bandoh S., Tokuda M., Tanimoto Y., Kataoka M., et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002, 22:89-92.
70. Lambert M., Hebbar M., Viget N., Hatron P.Y., Hachulla E., Devulder B. Bronchiolitis obliterans with organized pneumonia: a rare complication of primary Gougerot-Sjögren syndrome. Rev Med Interne 2000, 21(1):74-77.
71. Ioannou S., Toya S.P., Tomos P., Tzelepis G.E. Cryptogenic organizing pneumonia associated with primary Sjögren's syndrome. Rheumatol Int 2008, 28(10):1053-1055.
72. Matteson E.L., Ike R.W. Bronchiolitis obliterans organizing pneumonia and Sjögren's syndrome. J Rheumatol 1990, 17(5):676-679.
73. Usui Y., Kimula Y., Miura H., Kodaira Y., Takayama S., Nakayama M., et al. A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjögren's syndrome who died of superimposed diffuse alveolar damage. Respiration 1992, 59(2):122-124.
74. Foguem C., Launay D., Lambert M., Quemeneur T., Hachulla E., Wallaert B., et al. Cystic lung disease associated with Sjögren's syndrome: 2 cases. Rev Med Interne 2006, 27(8):620-624.
75. Young C., Hunt S., Watkinson A., Beynon H. Sjögren's syndrome, cavitating lung disease and high sustained levels of antibodies to serine proteinase 3. Scand J Rheumatol 2000, 29:267-269.
76. Bonner H., Ennis R.S., Geelhoed G.W., Tarpley T.M. Lymphoid infiltration and amyloidosis of lung in Sjögren's syndrome. Arch Pathol 1973, 95:42-44.
77. Hubscher O., Re R., Iotti R. Cystic lung disease in Sjögren's syndrome. J Rheumatol 2002, 29:2235-2236.
78. Sakamoto O., Saita N., Ando M., Kohrogi H., Suga M. Two cases of Sjögren's syndrome with multiple bullae. Intern Med 2002, 41:124-128.
79. Watanabe M., Naniwa T., Hara M., Arakawa T., Maeda T. Pulmonary manifestations in Sjögren's syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol 2010, 37:365-373.
80. Yousem S.A., Colby T.V., Carrington C.B. Follicular bronchitis/bronchiolitis. Hum Pathol 1985, 16:700-706.
81. Liebow A.A., Carrington C.B. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973, 57:809-843.
82. Swigris J.J., Berry G.J., Raffin T.A., Kuschner W.G. Lymphoid interstitial pneumonia: a narrative review. Chest 2002, 122:2150-2164.
83. Johkoh T., Muller N.L., Pickford H.A., Hartman T.E., Ichikado K., Akira M., et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999, 212:567-572.
84. Royer B., Cazals-Hatem D., Sibilia J., Agbalika F., Cayuela J.M., Soussi T., et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997, 90(2):766-775.
85. Hansen L.A., Prakash U.B., Colby T.V. Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc 1989, 64(8):920-931.
86. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009, 88(5):284-293.
87. Kojima M., Tsukamoto N., Yokohama A., Suzuki Y., Shimizu K., Nishikawa M., et al. B-cell lymphoma associated with Sjögren's syndrome among Japanese patients: a clinicopathologic and immunohistochemical study of 15 cases. J Clin Exp Hematop 2009, 49(2):89-95.
88. Graham B.B., Mathisen D.J., Mark E.J., Takvorian R.W. Primary pulmonary lymphoma. Ann Thorac Surg 2005, 80(4):1248-1253.
89. Cain H.C., Noble P.W., Matthay R.A. Pulmonary manifestations of Sjögren's syndrome. Clin Chest Med 1998, 19(4):687-699.
90. Papiris S.A., Kalomenidis I., Malagari K., Kapotsis G.E., Harhalakis N., Manali E.D., et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med 2007, 101(1):84-92.
91. Zompi S., Couderc L.J., Cadranel J., Antoine M., Epardeau B., Fleury-Feith J., et al. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood 2004, 103(8):3208-3215.
92. Cordier J.F., Chailleux E., Lauque D., Reynaud-Gaubert M., Dietemann-Molard A., Dalphin J.C., et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993, 103(1):201-208.
93. Pagani J.J., Collins J.D., Reza M.J. Sjögren syndrome presenting as pulmonary pseudolymphoma: report of a case. J Natl Med Assoc 1979, 71(7):677-678.
94. Teshigawara K., Kakizaki S., Horiya M., Kikuchi Y., Hashida T., Tomizawa Y., et al. Primary Sjögren's syndrome complicated by bilateral pleural effusion. Respirology 2008, 13(1):155-158.
95. Kawamata K., Haraoka H., Hirohata S., Hashimoto T., Jenkins R.N., Lipsky P.E. Pleurisy in primary Sjögren's syndrome: T cell receptor beta-chain variable region gene bias and local autoantibody production in the pleural effusion. Clin Exp Rheumatol 1997, 15(2):193-196.
96. Ogihara T., Nakatani A., Ito H., Irokawa M., Ban S., Takahashi A., et al. Sjögren's syndrome with pleural effusion. Intern Med 1995, 34(8):811.
97. Tavoni A., Vitali C., Cirigliano G., Frigelli S., Stampacchia G., Bombardieri S. Shrinking lung in primary Sjögren's syndrome. Arthritis Rheum 1999, 42:2249-2250.
98. Rajagopala S., Singh N., Gupta K., Gupta D. Pulmonary amyloidosis in Sjögren's syndrome: a case report and systematic review of the literature. Respirology 2010, 15:860-868.
99. Wong B.C., Wong K.L., Ip M.S., Wang E.P., Chan K.W., Cheng L.C. Sjögren's syndrome with amyloid A presenting as multiple pulmonary nodules. J. Rheumatol 1994, 21:165-167.
100. Eri Z., Stanic J., Duric D., et al. Nodular amyloidosis of the lungs associated with Sjögren's syndrome. Plucne Bolesti 1990, 42:153-155.
101. Hui A.N., Koss M.N., Hochholzer L., Wehunt W.D. Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases. Arch Pathol Lab Med 1986, 110:212-218.
102. Galie N., Hoeper M.M., Humbert M., Torbicki A., Vachiery J.L., Barbera J.A., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009, 34:1219-1263.
103. Simonneau G., Robbins I.M., Beghetti M., Channick R.N., Delcroix M., Denton C.P., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43-S54.
104. Cottin V. Pulmonary arterial hypertension in connective tissue disease. Rev Mal Respir 2006, 23(13):S61-S72.
105. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006, 173:1023-1030.
106. Hachulla E., Gressin V., Guillevin L., Carpentier P., Diot E., Sibilia J., et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005, 52:3792-3800.
107. Hassoun P.M. Pulmonary arterial hypertension complicating connective tissue diseases. Semin Respir Crit Care Med 2009, 30:429-439.
108. Hachulla E., de Groote P., Gressin V., Sibilia J., Diot E., Carpentier P., et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009, 60:1831-1839.
109. Skopouli F.N., Dafni U., Ioannidis J.P., Moutsopoulos H.M. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000, 29:296-304.
110. Quismorio F.P. Pulmonary involvement in primary Sjögren's syndrome. Curr Opin Pulm Med 1996, 2:424-428.
111. Launay D., Hachulla E., Hatron P.Y., et al. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007, 86:299-315.
112. Aoki A., Kenmochi H., Hagiwara E., et al. Pulmonary hypertension in a patient with primary Sjögren's syndrome. Hashimoto's disease, and primary biliary cirrhosis. Nihon Rinsho Meneki Gakkai Kaishi 2000, 23:462-469.
113. Aslaksen H.K., Nossent H.C. Fatal pulmonary hypertension in primary Sjögren's syndrome. Clin Exp Rheumatol 2004, 22:507.
114. Bertoni M., Niccoli L., Porciello G., et al. Pulmonary hypertension in primary Sjögren's syndrome: report of a case and review of the literature. Clin Rheumatol 2005, 24:431-434.
115. Biyajima S., Osada T., Daidoji H., et al. Pulmonary hypertension and antiphospholipid antibody in a patient with Sjögren's syndrome. Intern Med 1994, 33:768-772.
116. Chen C.H., Chen H.A., Wang H.P., et al. Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. J Microbiol Immunol Infect 2006, 39:162-168.
117. Chen C.H., Chen H.A., Yang K.Y., et al. Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension. Scand J Rheumatol 2006, 35:245-247.
118. Fox R.I., Howell F.V., Bone R.C., Michelson P. Primary Sjögren syndrome: clinical andimmunopathologic features. Semin Arthritis Rheum 1984, 14:77-105.
119. Funayama N., Haneda T., Yamashita H., et al. A case of Sjögren's syndrome associated with pulmonary hypertension. Kokyu To Junkan 1984, 32:415-419.
120. Gallerani M., Govoni M., Ricci L., et al. A 49-year-old woman with dyspnoea, palpitations and syncope. Int J Cardiol 1996, 55:67-78.
121. Gimeno J.V., Cebolla R., Palacios V., et al. Pulmonary hypertension in Sjögren's syndrome: an uncommon association. Rev Esp Cardiol 1985, 38:69-71.
122. Gotoh T., Akizuki S., Handa S., et al. Case of Sjögren's syndrome associated with pulmonary hypertension. Kokyu To Junkan 1983, 31:1011-1018.
123. Handa S., Akaishi M., Iwanaga S., et al. Prognosis of patients with primary pulmonary hypertension. J Cardiol 1989, 19:877-884.
124. Hedgpeth M.T., Boulware D.W. Pulmonary hypertension in primary Sjögren's syndrome. Ann Rheum Dis 1988, 47:251-253.
125. Mariette X., Brenot F., Brouet J.C. Recovery from pulmonary hypertension with steroid therapy in apatient with Sjögren's syndrome and polymyositis. J Rheumatol 1994, 21:772-773.
126. Masuyama J., Takeda A., Sumiya M. A case of Sjögren's syndrome with pulmonary hypertension. Nippon Rinsho 1982, 5:314-319.
127. Muto S., Honma S., Takayasu T., et al. A case of Sjögren's syndrome associated with pulmonary embolism, monoclonal hypergammaglobulinemia, and thymoma. Nippon Naika Gakkai Zasshi 1984, 73:1001-1008.
128. Nakagawa N., Osanai S., Ide H., et al. Severe pulmonary hypertension associated with primary Sjögren's syndrome. Intern Med 2003, 42:1248-1252.
129. Nishido T., Miyasaka N., Kawamitsu H., Okuda M., Nasu M. Prognostic aspect of Sjögren's syndrome. A clinicaopathologic study of eight fatal cases. Jpn J Med 1981, 20:2-10.
130. Ohnishi H., Yabe H., Fujiyama R., et al. Sjögren's syndrome with malignant lymphoma, interstitial pneumonia, and pulmonary hypertension. Nihon Kokyuki Gakkai Zasshi 2000, 38:190-194.
131. Sakimura K., Aizawa Y., Watanabe K., Yoshizaki T., Shibata A. A case of Sjögren's syndrome with pulmonary hypertension, hypergammaglobulinemia and thrombocytopenia (author's transl). Nippon Naika Gakkai Zasshi 1982, 71:71-76.
132. Sato T., Matsubara O., Tanaka Y., Kasuga T. Association of Sjögren's syndrome with pulmonary hypertension: report of two cases and review of the literature. Hum Pathol 1993, 24:199-205.
133. Sowa J.M. The association of Sjögren's syndrome and primary pulmonary hypertension. Hum Pathol 1993, 24:1035-1036.
134. Tatsukawa H., Nagano S., Umeno Y., Oribe M. A case of primary Sjögren's syndrome with severe pulmonary hypertension and glomerular damage. Ryumachi 2003, 43:564-568.
135. Usui K., Anzai C., Sano K., Kumazaki S., Ishihara T. Primary Sjögren's syndrome with pulmonary hypertension. Nihon Kokyuki Gakkai Zasshi 1998, 36:478-481.
136. Vallalta Morales M., Mico Giner L., Munoz Guillem M.L., Calabuig Alborch J.R. Pulmonary arterial hypertension and Sjögren's syndrome: and uncommon association. Med Clin (Barc) 2004, 123:758-759.
137. Anon. Pulmonary hypertension and Sjögren's syndrome. Medicina (B Aires) 1987, 47:529-533.
138. Sitbon O., Humbert M., Jais X., et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005, 111:3105-3111.
139. Keith M.P., Moratz C., Tsokos G.C. Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev 2007, 6:232-236.
140. Tamby M.C., Chanseaud Y., Humbert M., et al. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005, 60:765-772.
141. Devauchelle-Pensec V., Pennec Y., Morvan J., et al. Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum 2007, 57:310-317.
142. Meijer J.M., Pijpe J., Vissink A., Kallenberg C.G., Bootsma H. Treatment of primary Sjögren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment. Ann Rheum Dis 2009, 68:284-285.
143. Seror R., Sordet C., Guillevin L., et al. 2006. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome. Ann Rheum Dis 2007, 66:351-357.
144. Manoussakis M.N., Moutsopoulos H.M. Sjögren's syndrome: current concepts. Adv Intern Med 2001, 47:191-217.
145. Dalvi V., Gonzalez E.B., Lovett L. Lymphocytic interstitial pneumonitis (LIP) in Sjögren's syndrome: a case report and a review of the literature. Clin Rheumatol 2007, 26:1339-1343.
146. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61(6):554-558.